Compare Dishman Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs DR. REDDYS LAB - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA DR. REDDYS LAB DISHMAN PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 25.1 34.3 73.2% View Chart
P/BV x 3.3 4.7 71.3% View Chart
Dividend Yield % 0.7 0.6 117.4%  

Financials

 DISHMAN PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
DR. REDDYS LAB
Mar-20
DISHMAN PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3743,363 11.1%   
Low Rs1292,352 5.5%   
Sales per share (Unadj.) Rs197.81,054.2 18.8%  
Earnings per share (Unadj.) Rs21.2121.9 17.4%  
Cash flow per share (Unadj.) Rs34.7190.2 18.3%  
Dividends per share (Unadj.) Rs2.0025.00 8.0%  
Dividend yield (eoy) %0.80.9 90.8%  
Book value per share (Unadj.) Rs179.9938.7 19.2%  
Shares outstanding (eoy) m80.69166.17 48.6%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.32.7 46.9%   
Avg P/E ratio x11.923.4 50.6%  
P/CF ratio (eoy) x7.215.0 48.2%  
Price / Book Value ratio x1.43.0 46.0%  
Dividend payout %9.420.5 46.0%   
Avg Mkt Cap Rs m20,306474,831 4.3%   
No. of employees `0000.821.7 3.8%   
Total wages/salary Rs m5,35533,802 15.8%   
Avg. sales/employee Rs Th19,252.78,091.0 238.0%   
Avg. wages/employee Rs Th6,459.51,561.3 413.7%   
Avg. net profit/employee Rs Th2,064.1935.8 220.6%   
INCOME DATA
Net Sales Rs m15,961175,170 9.1%  
Other income Rs m2656,206 4.3%   
Total revenues Rs m16,226181,376 8.9%   
Gross profit Rs m4,10324,421 16.8%  
Depreciation Rs m1,09111,348 9.6%   
Interest Rs m944983 96.1%   
Profit before tax Rs m2,33418,296 12.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m1561 0.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624-1,403 -44.4%   
Profit after tax Rs m1,71120,260 8.4%  
Gross profit margin %25.713.9 184.4%  
Effective tax rate %26.7-7.7 -348.5%   
Net profit margin %10.711.6 92.7%  
BALANCE SHEET DATA
Current assets Rs m11,018125,991 8.7%   
Current liabilities Rs m9,51772,141 13.2%   
Net working cap to sales %9.430.7 30.6%  
Current ratio x1.21.7 66.3%  
Inventory Days Days11073 151.2%  
Debtors Days Days35105 33.3%  
Net fixed assets Rs m16,30483,854 19.4%   
Share capital Rs m161831 19.4%   
"Free" reserves Rs m12,907155,157 8.3%   
Net worth Rs m14,516155,988 9.3%   
Long term debt Rs m4,1891,304 321.3%   
Total assets Rs m29,805232,253 12.8%  
Interest coverage x3.519.6 17.7%   
Debt to equity ratio x0.30 3,452.5%  
Sales to assets ratio x0.50.8 71.0%   
Return on assets %8.99.1 97.4%  
Return on equity %11.813.0 90.8%  
Return on capital %17.512.6 139.0%  
Exports to sales %24.80-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m596NA-   
Fx inflow Rs m4,95284,193 5.9%   
Fx outflow Rs m69739,616 1.8%   
Net fx Rs m4,25544,577 9.5%   
CASH FLOW
From Operations Rs m2,78629,841 9.3%  
From Investments Rs m-1,529-4,923 31.1%  
From Financial Activity Rs m-941-25,159 3.7%  
Net Cashflow Rs m316-266 -118.9%  

Share Holding

Indian Promoters % 61.4 25.5 240.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 5.4 68.5%  
FIIs % 12.7 35.3 36.0%  
ADR/GDR % 0.0 18.5 -  
Free float % 22.1 15.3 144.4%  
Shareholders   46,261 75,885 61.0%  
Pledged promoter(s) holding % 35.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   JUBILANT PHARMOVA   DR. DATSONS LABS  WOCKHARDT  GSK PHARMA  PANACEA BIOTECH  

Compare DISHMAN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 200 Points Higher; Dow Futures Up by 165 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 299 points, up 0.6% at 50,739 levels.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 8-QTR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS